Matthew Winton Diffusion Pharmaceuticals Inc. (DFFN) insider trading activity

DFFN Quotes by TradingView

Matthew Winton is Chief Commercial and Business of Diffusion Pharmaceuticals Inc.. Currently has a direct ownership of 15,000 shares of DFFN, which is worth approximately $138,750. The most recent transaction as insider was on Nov 18, 2025, when has been sold 1,500 shares (Common Stock) at a price of $7.95 per share, resulting in proceeds of $11,925. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
n/a 3M change
n/a 12M change
Total Value Held $138,750

Matthew Winton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2025
BUY
Open market or private purchase
$11,925 $7.95 p/Share
1,500 Added 9.09%
15,000 Common Stock
Nov 17 2025
BUY
Open market or private purchase
$29,505 $8.43 p/Share
3,500 Added 20.59%
13,500 Common Stock
Nov 14 2025
BUY
Open market or private purchase
$75,700 $7.57 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

INZY
Inozyme Pharma, Inc. Healthcare
COO
MW

Matthew Winton

Chief Commercial and Business
Boston, MA

Track Institutional and Insider Activities on DFFN

Follow Diffusion Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DFFN shares.

Notify only if

Insider Trading

Get notified when an Diffusion Pharmaceuticals Inc. insider buys or sells DFFN shares.

Notify only if

News

Receive news related to Diffusion Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DFFN